Medis Medical Imaging Welcomes Jason Fuller as Vice President of Sales, North America & Global Head of Customer Success

Medis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the USA

Read More

Medis Medical Imaging Appoints Martijn van Lavieren as Head of Clinical Strategy and Business Development.

Medis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the USA

Read More

FAVOR III Europe substudy confirms that Medis QFR® compares to the FFR standard

Medis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the USA

Read More

Medis QFR® 3.0 Launches in the U.S.

Medis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the USA

Read More

Terumo Health Outcomes and Medis Medical Imaging announce Strategic Partnership to enhance Cardiovascular Care

Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software company, announced today that they have entered into a strategic partnership, in the United States, to enhance cardiovascular care through the utilization of both ePRISM – Terumo’s proprietary clinical decision support platform – and Medis’ Quantitative Flow Ratio (QFR) technology, a non-invasive software solution designed to assess angiography-derived coronary physiology.

Read More

QFR® awarded Class I recommendation in 3 categories of the 2024 ESC guidelines for the management of Chronic Coronary Syndrome.

Medis’ Quantitative Flow Ratio (QFR®) has been awarded with a Class I recommendation in 3 distinct categories of the 2024 ESC guidelines for the management of patients suffering from chronic coronary syndrome (CCS). This recognition recommends QFR® as a physiology measurement technique next to, and at par with, the traditional wire-based methods. The guidelines also differentiate Medis QFR® from other Angiography-based FFR techniques, which have been called out with a lower IIb/C recommendation, in only one of the 3 categories.

Read More